Intercept files for IPO

Intercept Pharmaceuticals Inc. (New York, N.Y.) proposed to raise up to $75 million in an IPO underwritten by BofA Merrill Lynch; BMO Capital Markets; Needham; Wedbush; and ThinkEquity. Intercept's ob...